Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 84

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 84
---
 acknowledges that it understands that failure to comply with a Disclosure
Notice may result in the imposition of sanctions against the holder of the underlying Ordinary Shares in respect of which the non-complying
person is or was, or appears to be or has been, interested as provided in the Companies Act and the Articles of Association which currently
may include, subject to the granting of an appropriate order by the court, the withdrawal of the voting rights of such Ordinary Shares
and the imposition of restrictions on the rights to receive dividends on and to transfer such Ordinary Shares. In addition, each ADR holder
agrees to comply with the provisions of the Disclosure Guidance and Transparency Rules published by the United Kingdom Financial Conduct
Authority (as amended from time to time) with regard to the notification to the Company of interests in Ordinary Shares underlying Depositary
Shares and certain financial instruments, which currently provide, inter alia, that an ADR holder must notify the Company
of the percentage of its voting rights he holds as a shareholder or holds or is deemed to hold through his direct or indirect holding
of certain financial instruments (or a combination of such holdings) if the percentage of those voting rights reaches, exceeds or falls
below specified thresholds.

Books of Depositary

The depositary or its
agent will maintain a register for the registration, registration of transfer, combination and split-up of ADRs, which register shall
include the depositary’s direct registration system. Registered holders of ADRs may inspect such records at the depositary’s
office at all reasonable times, but solely for the purpose of communicating with other ADR holders in the interest of the business of
our Company or a matter relating to the Deposit Agreement. Such register (and/or any portion thereof) may be closed at any time or from
time to time, when deemed expedient by the depositary.

The depositary will maintain
facilities for the delivery and receipt of ADRs.

Appointment

In the Deposit Agreement,
each registered holder of ADRs and each beneficial owner, upon acceptance of any Depositary Shares or ADRs (or any interest in any of
them) issued in accordance with the terms and conditions of the Deposit Agreement will be deemed for all purposes to:

| · | be a party to and bound by the terms of the Deposit Agreement and the applicable ADR or ADRs, |

| · | appoint the depositary its attorney-in-fact, with full power to delegate, to act on its behalf and to                                      
 take any and